| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOGEN INC | 625,096 | 182,409,000 | 8.36% | ||
| 2 | GILEAD SCIENCES INC | 1,856,458 | 182,286,000 | 8.35% | ||
| 3 | CELGENE CORP | 1,267,158 | 137,068,000 | 6.28% | ||
| 4 | REGENERON PHARMACEUTICALS | 244,100 | 113,541,000 | 5.20% | ||
| 5 | ALEXION PHARMACEUTIC | 721,593 | 112,850,000 | 5.17% | ||
| 6 | BIOMARIN | 969,823 | 102,142,000 | 4.68% | ||
| 7 | INCYTE | 887,051 | 97,868,000 | 4.48% | ||
| 8 | AMICUS THERAPEUTICS INC | 6,111,227 | 85,496,000 | 3.92% | ||
| 9 | AMGEN INC | 554,697 | 76,726,000 | 3.51% | ||
| 10 | VERTEX PHARMACEUT | 734,200 | 76,460,000 | 3.50% | ||
| 11 | THERMO FISHER SCIENTIFIC INC | 605,636 | 74,057,000 | 3.39% | ||
| 12 | MERCK & CO INC | 1,097,376 | 54,199,000 | 2.48% | ||
| 13 | PFIZER INC | 1,711,016 | 53,743,000 | 2.46% | ||
| 14 | SEATTLE GENETICS INC | 1,269,075 | 48,936,000 | 2.24% | ||
| 15 | PORTOLA PHARMACEUTICALS INC | 1,088,118 | 46,376,000 | 2.12% | ||
| 16 | ALLERGAN PLC | 142,009 | 38,599,000 | 1.77% | ||
| 17 | INTERCEPT PHARMACEUTICAL | 219,647 | 36,431,000 | 1.67% | ||
| 18 | HALOZYME THERAPEUTICS INC | 2,671,051 | 35,872,000 | 1.64% | ||
| 19 | MEDTRONIC PLC | 525,952 | 35,207,000 | 1.61% | ||
| 20 | TEVA PHARMACEUTICAL INDS LTD | 594,950 | 33,591,000 | 1.54% | ||
| 21 | ALIGN TECHNOLOGY INC | 512,393 | 29,083,000 | 1.33% | ||
| 22 | DEXCOM | 323,233 | 27,753,000 | 1.27% | ||
| 23 | SHIRE PLC | 122,056 | 25,050,000 | 1.15% | ||
| 24 | ALDER BIOPHARMACEUTICALS INC | 762,682 | 24,985,000 | 1.14% | ||
| 25 | UNITED THERAPEUTICS | 175,780 | 23,069,000 | 1.06% | ||
| 26 | ST JUDE | 354,911 | 22,391,000 | 1.03% | ||
| 27 | UNITEDHEALTH GROUP INC | 191,148 | 22,175,000 | 1.02% | ||
| 28 | EDWARDS LIFESCIENCES CORP | 153,115 | 21,768,000 | 1.00% | ||
| 29 | AIMMUNE THERAPEUTICS INC COM | 792,638 | 20,070,000 | 0.92% | ||
| 30 | PTC THERAPEUTICS INC | 690,364 | 18,433,000 | 0.84% | ||
| 31 | CHIMERIX INC | 476,500 | 18,202,000 | 0.83% | ||
| 32 | ProNAi Therapeutics, Inc. | 862,766 | 17,290,000 | 0.79% | ||
| 33 | MYLAN N V | 417,082 | 16,792,000 | 0.77% | ||
| 34 | DR REDDYS LABS LTD | 254,901 | 16,291,000 | 0.75% | ||
| 35 | RELYPSA INC | 842,030 | 15,586,000 | 0.71% | ||
| 36 | UNIQURE NV | 761,913 | 15,581,000 | 0.71% | ||
| 37 | ACCELERON PHARMA | 612,184 | 15,243,000 | 0.70% | ||
| 38 | TG THERAPEUTICS INC COM | 1,464,105 | 14,758,000 | 0.68% | ||
| 39 | CARA THERAPEUTICS INC | 1,023,309 | 14,623,000 | 0.67% | ||
| 40 | NOVARTIS A G | 145,305 | 13,356,000 | 0.61% | ||
| 41 | ADVAXIS INC COM NEW | 1,263,415 | 12,925,000 | 0.59% | ||
| 42 | NOVO-NORDISK A S | 235,375 | 12,767,000 | 0.58% | ||
| 43 | Heartware International, Inc. | 224,580 | 11,748,000 | 0.54% | ||
| 44 | NXSTAGE MED INC COM | 712,329 | 11,233,000 | 0.51% | ||
| 45 | INTUITIVE SURGICAL INC | 24,096 | 11,074,000 | 0.51% | ||
| 46 | REGENXBIO INC COM | 507,441 | 10,834,000 | 0.50% | ||
| 47 | IMMUNE DESIGN CORP COM | 845,867 | 10,320,000 | 0.47% | ||
| 48 | Teladoc, Inc. | 417,700 | 9,311,000 | 0.43% | ||
| 49 | SAGENT PHARMACEUTICALS INC | 585,659 | 8,978,000 | 0.41% | ||
| 50 | ACADIA HEALTHCARE COMPANY IN | 128,054 | 8,486,000 | 0.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-15-078664, filed 2015.11.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
